Kidney Research and Clinical Practice

Which blood pressure metrics should be used in patients on dialysis?: Ji Yong Jung; Kidney Res Clin Pract. 2024;43(2):133-142. Published online November 14, 2023; DOI: https://doi.org/10.23876/j.krcp.23.126; Full text PubReader ePub PDF

Predictive performance of the new race-free Chronic Kidney Disease Epidemiology Collaboration equations for kidney outcome in Korean patients with chronic kidney disease: Hyoungnae Kim, Young Youl Hyun, Hae-Ryong Yun et al.; Kidney Res Clin Pract. 2023;42(4):501-511. Published online March 22, 2023; DOI: https://doi.org/10.23876/j.krcp.22.158
Web of Science 4 Cited By 3; Full text PubReader ePub PDF Supplementary Material

Serum calcification propensity and its association with biochemical parameters and bone mineral density in hemodialysis patients: Hyunsook Kim, Ae Jin Kim, Han Ro et al.; Kidney Res Clin Pract. 2023;42(2):262-271. Published online October 25, 2022; DOI: https://doi.org/10.23876/j.krcp.22.059
Web of Science 1 Cited By 1; Full text PubReader ePub PDF

Blood pressure management in treatment-naïve hypertensive patients: Ji Yong Jung; Kidney Res Clin Pract. 2022;41(1):1-3. Published online January 10, 2022; DOI: https://doi.org/10.23876/j.krcp.21.263
Web of Science 1 Cited By 1; Full text PubReader ePub PDF

Korean Society of Nephrology 2021 Clinical Practice Guideline for Optimal Hemodialysis Treatment: Ji Yong Jung, Kyung Don Yoo, Eunjeong Kang et al.; Kidney Res Clin Pract. 2021;40(Suppl 1):S1-S37. Published online December 10, 2021; DOI: https://doi.org/10.23876/j.krcp.21.600
Cited By 7; Full text PubReader ePub PDF Supplementary Material

Executive Summary of the Korean Society of Nephrology 2021 Clinical Practice Guideline for Optimal Hemodialysis Treatment: Ji Yong Jung, Kyung Don Yoo, Eunjeong Kang et al.; Kidney Res Clin Pract. 2021;40(4):578-595. Published online December 10, 2021; The full-text version of this CPG is available on the KRCP website (https://doi.org/10.23876/j.krcp.21.600).; DOI: https://doi.org/10.23876/j.krcp.21.700
Web of Science 3 Cited By 3; Full text PubReader ePub PDF

Elevated levels of soluble ST2 but not galectin-3 are associated with increased risk of mortality in hemodialysis patients: Ae Jin Kim, Han Ro, Hyunsook Kim et al.; Kidney Res Clin Pract. 2021;40(1):109-119. Published online March 5, 2021; DOI: https://doi.org/10.23876/j.krcp.20.133
Web of Science 3 Cited By 3; Full text PubReader ePub PDF Supplementary Material

Intensity of statin therapy and renal outcome in chronic kidney disease: Results from the Korean Cohort Study for Outcome in Patients With Chronic Kidney Disease: Jong Hyun Jhee, Young Su Joo, Jung Tak Park et al.; Kidney Res Clin Pract. 2020;39(1):93-102. Published online March 31, 2020; DOI: https://doi.org/10.23876/j.krcp.20.007
Web of Science 5 Cited By 6; Full text PubReader PDF Supplementary Material

Stabilization of serum alkaline phosphatase in hemodialysis patients by implementation of local chronic kidney disease-mineral bone disorder management strategy: A quality improvement study: Kyubok Jin, Tae Hyun Ban, Ji Yong Jung et al.; Kidney Res Clin Pract. 2018;37(2):157-166. Published online June 30, 2018; DOI: https://doi.org/10.23876/j.krcp.2018.37.2.157
Web of Science 4 Cited By 4; Full text PubReader PDF

14,699	Validation of operational definitions of mortality in a nationwide hemodialysis population using the Health Insurance Review and Assessment Service databases of Korea
19,701	C4d Puzzle in ABO-incompatible kidney transplantation
8,132	How should we treat acute kidney injury caused by renal congestion?
12,849	Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options
34,916	Uremic pruritus: pathophysiology, clinical presentation, and treatments

Cited By 14	Association between blood pressure and the risk of chronic kidney disease in treatment-naïve hypertensive patients
Cited By 13	Exploring molecular targets in diabetic kidney disease
Cited By 13	Application of C5 inhibitors in glomerular diseases in 2021
Cited By 13	GLP-1 receptor agonists in diabetic kidney disease: current evidence and future directions
Cited By 11	Prostaglandin E2 receptors as therapeutic targets in renal fibrosis

Search